Histone deacetylase mediates the decrease in drebrin cluster density induced by amyloid beta oligomers

Area of Science:

• Neuroscience
• Molecular Biology
• Cell Biology

Background:

• Dendritic spine defects are implicated in cognitive disorders like Alzheimer's disease (AD).
• Amyloid beta (Aβ) toxicity, particularly from soluble oligomers (ADDLs), contributes to synaptic dysfunction.
• Drebrin, an actin-binding protein at dendritic spines, is reduced in AD and Aβ-exposed neurons.

Purpose of the Study:

• To investigate the role of histone deacetylase (HDAC) activity in ADDL-induced synaptic defects.
• To examine if HDAC inhibition can prevent ADDL-induced loss of drebrin clusters at dendritic spines.

Main Methods:

• Utilized suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor, in cultured neurons exposed to ADDLs.
• Quantified drebrin cluster density along dendrites and assessed histone acetylation levels.
• Evaluated the impact of SAHA on dendritic protrusions and drebrin cluster density in control and ADDL-treated neurons.

Main Results:

• ADDLs reduced drebrin cluster density without altering overall drebrin expression.
• SAHA treatment increased histone acetylation and prevented the ADDL-induced decrease in drebrin cluster density.
• SAHA did not affect drebrin cluster or dendritic protrusion density in control neurons, suggesting stabilization rather than promotion.

Conclusions:

• HDAC activity is involved in ADDL-induced synaptic defects, specifically impacting drebrin localization.
• Histone acetylation regulation is crucial for maintaining dendritic spine actin dynamics under cellular stress like ADDL exposure.
• HDAC inhibition offers a potential therapeutic avenue for synaptic dysfunction in conditions like Alzheimer's disease.